INSM: Insmed Incorporated Stock

by  •  • Comments Off on INSM: Insmed Incorporated Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 14,671.81
Enterprise Value ($M) 15,381.23
Book Value ($M) 285.38
Book Value / Share 1.58
Price / Book 51.41
NCAV ($M) -118.19
NCAV / Share -0.65
Price / NCAV -124.14

Profitability (mra)
Return on Invested Capital (ROIC) -0.57
Return on Assets (ROA) -0.69
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 5.12
Current Ratio 5.45

Balance Sheet (mrq) ($M)
Current Assets 1,621.66
Assets 2,025.23
Liabilities 1,739.85
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 363.71
Operating Income -786.57
Net Income -913.77
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -683.88
Cash from Investing -583.17
Cash from Financing 1,341.02

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Darwin Global Management, Ltd.
01-08 13G/A Vanguard Group Inc
11-14 13G/A Price T Rowe Associates Inc /md/ 7.30 16.72
2024-02-16 13G/A T. Rowe Price Investment Management, Inc. 4.10 0.00
2024-01-25 13G/A BlackRock, Inc. 8.00 3.41
2024-01-22 13G/A State Street Corp 4.15 -13.89

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PUR
2024-10-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-24 386,431 1,362,800 28.36
2025-02-21 802,779 2,220,314 36.16
2025-02-20 711,780 1,949,904 36.50
2025-02-19 620,095 1,877,842 33.02

(click for more detail)

Similar Companies
INBX – Inhibrx Biosciences, Inc. INDV – Indivior PLC
INNV – InnovAge Holding Corp. INVA – Innoviva, Inc.
INZY – Inozyme Pharma, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Insmed